Strain differences in mice with invasive bladder carcinomas induced by N-butyl-N-(4-hydroxybutyl)nitrosamine
- PMID: 3771618
- PMCID: PMC12252795
- DOI: 10.1007/BF00404391
Strain differences in mice with invasive bladder carcinomas induced by N-butyl-N-(4-hydroxybutyl)nitrosamine
Abstract
Papillary superficial and nonpapillary invasive bladder carcinomas of humans are two disease entities exhibiting completely different biological behavior. Studies were performed on the susceptibilities of various strains of mice to induction of bladder carcinomas by N-butyl-N-(4-hydroxybutyl)nitrosamine (BHBN), and the type of carcinomas that developed. BHBN at concentrations of 0.05% and 0.01% in drinking water was given to female mice of strains A/Jax, AKR/Jax, C3H/He, DBA/2, and C57BL/6 for 22 weeks. The incidence of nonpapillary invasive bladder carcinomas in these strains was 40%, 100%, 100%, 89%, and 89%, respectively, in groups treated with 0.05% BHBN and 30%, 60%, 60%, 90%, and 40%, respectively, in groups treated with 0.01% BHBN. At both levels BHBN and in all strains the bladder carcinomas induced were of the nonpapillary invasive type.
Similar articles
-
Sequential changes of mouse bladder epithelium during induction of invasive carcinomas by N-butyl-N-(4-hydroxybutyl)nitrosamine.Cancer Res. 1986 Apr;46(4 Pt 2):2001-4. Cancer Res. 1986. PMID: 3948177
-
Long-term administration of galactoside-specific mistletoe lectin in an animal model: no protection against N-butyl-N-(4-hydroxybutyl)-nitrosamine-induced urinary bladder carcinogenesis in rats and no induction of a relevant local cellular immune response.J Cancer Res Clin Oncol. 2000 Mar;126(3):125-38. doi: 10.1007/s004320050022. J Cancer Res Clin Oncol. 2000. PMID: 10741906 Free PMC article.
-
Acetylsalicylic acid inhibition of n-butyl-(4-hydroxybutyl)nitrosamine-induced bladder carcinogenesis in rats.J Cancer Res Clin Oncol. 1993;119(8):482-5. doi: 10.1007/BF01215929. J Cancer Res Clin Oncol. 1993. PMID: 8509438 Free PMC article.
-
Intravesical gemcitabine for non-muscle invasive bladder cancer.Cochrane Database Syst Rev. 2012 Jan 18;1:CD009294. doi: 10.1002/14651858.CD009294.pub2. Cochrane Database Syst Rev. 2012. Update in: Cochrane Database Syst Rev. 2021 Jun 14;6:CD009294. doi: 10.1002/14651858.CD009294.pub3. PMID: 22259002 Updated.
-
Unmet Need in Non-muscle-invasive Bladder Cancer Failing Bacillus Calmette-Guérin Therapy: A Systematic Review and Cost-effectiveness Analyses from the International Bladder Cancer Group.Eur Urol Oncol. 2025 Feb;8(1):216-229. doi: 10.1016/j.euo.2024.10.012. Epub 2024 Nov 15. Eur Urol Oncol. 2025. PMID: 39550339
Cited by
-
Quantitative trait loci associated with promoting effects of sodium L-ascorbate on two-stage bladder carcinogenesis in rats.Jpn J Cancer Res. 1997 Jul;88(7):633-8. doi: 10.1111/j.1349-7006.1997.tb00430.x. Jpn J Cancer Res. 1997. PMID: 9310135 Free PMC article.
-
Carcinogen-induced bladder cancer in the FVB mouse strain is associated with glandular differentiation and increased Cd274/Pdl-1 expression.Am J Clin Exp Urol. 2019 Jun 15;7(3):139-152. eCollection 2019. Am J Clin Exp Urol. 2019. PMID: 31317053 Free PMC article.
-
Active surveillance for nonmuscle invasive bladder cancer.Investig Clin Urol. 2016 Jun;57 Suppl 1(Suppl 1):S4-S13. doi: 10.4111/icu.2016.57.S1.S4. Epub 2016 May 27. Investig Clin Urol. 2016. PMID: 27326406 Free PMC article. Review.
-
Histopathological analysis of invasive bladder carcinomas induced by 3,2'-dimethyl-4-aminobiphenyl in hamsters.Jpn J Cancer Res. 1996 Jan;87(1):37-43. doi: 10.1111/j.1349-7006.1996.tb00197.x. Jpn J Cancer Res. 1996. PMID: 8609046 Free PMC article.
-
Time- and dose-dependent induction of invasive urinary bladder cancers by N-ethyl-N-(4-hydroxybutyl)nitrosamine in B6C3F1 mice.Jpn J Cancer Res. 1991 Jun;82(6):650-6. doi: 10.1111/j.1349-7006.1991.tb01900.x. Jpn J Cancer Res. 1991. PMID: 1906851 Free PMC article.
References
-
- Akagi G, Akagi A, Kimura M, Ohtsuka H (1973) Comparison of bladder tumors induced in rats and mice with N-butyl-N-(4-hydroxybutyl)-nitrosamine. Gann 64:331–336 - PubMed
-
- Becci PJ, Thompson HJ, Grubbs CJ, Squire RA, Brawn CC, Sporn MJ, Moon RC (1978) Inhibitory effect of 13-cis-retinoic acid on urinary bladder carcinogenesis induced in C57BL/6 mice by N-butyl-N-(4-hydroxybutyl)nitrosamine. Cancer Res 38:4463–4466 - PubMed
-
- Bertram JS, Craig AW (1972) Specific induction of bladder cancer in mice by N-butyl-N-(4-hydroxybutyl)nitrosamine and the effects of hormonal modifications of the sex difference in response. Eur J Cancer 8:587–594 - PubMed
-
- Brawn PN (1982) The origin of invasive carcinoma of the bladder. Cancer 50:515–519 - PubMed
-
- Cutler SJ, Heney NM, Friedell GH (1982) Longitudinal study of patients with bladder cancer: Factors associated with disease recurrence and progression. In: Bonny WW, Prout GR Jr (eds), Bladder cancer. Williams and Wilkins, Baltimore, London, pp 35–46
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical